Sera Prognostics, Inc. (SERA) AI-Powered Stock Analysis
See how Sera Prognostics, Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
SERA●NASDAQ
HealthcareMedical - Diagnostics & Research
$2.29
$0.04(2.004%)
U.S. Market opens in 51h 49m
Advertisement
Sera Prognostics, Inc. (SERA)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerSera Prognostics, Inc. (SERA) Stock Overall Grade
Sera Prognostics, Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Sera Prognostics, Inc.'s overall stock rating.
Forecast
C+Score
54/100Financial Growth
AScore
85/100Fundamental Growth
DScore
33/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
B+Score
75/100Sera Prognostics, Inc. (SERA) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 54/100 (C+), reflecting weak confidence in its potential. Financial Growth (85/100, A) and Fundamental Growth (33/100, D) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), it shows competitive strength. Analyst Consensus (75/100,B+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Sera Prognostics, Inc. stock grade, including financials, comparisons, and forecasts.